ARIAD to Present at the Jefferies 2016 Global Healthcare Conference
June 01 2016 - 6:35AM
Business Wire
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that
it will present at the Jefferies 2016 Global Healthcare Conference
being held in New York City. Paris Panayiotopoulos, president and
chief executive officer, will provide an overview of the Company’s
business on Wednesday, June 8, 2016 at 11:00 a.m. (ET).
The ARIAD presentation will be webcast live and can be accessed
by visiting the investor relations section of the Company's website
at http://www.ariad.com/investor. A replay of the presentation will
also be available and archived on the site for three weeks.
About ARIAD
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge,
Massachusetts, is an orphan oncology company focused on
transforming the lives of cancer patients with breakthrough
medicines. ARIAD is working on new medicines to advance the
treatment of various forms of chronic and acute leukemia, lung
cancer and other difficult-to-treat orphan cancers. ARIAD utilizes
computational and structural approaches to design small-molecule
drugs that overcome resistance to existing cancer medicines. For
additional information, visit http://www.ariad.com or follow ARIAD
on Twitter (@ARIADPharm).
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160601005189/en/
ARIAD Pharmaceuticals, Inc.For InvestorsMaria Cantor,
617-621-2208Maria.cantor@ariad.comorFor MediaLiza Heapes,
617-621-2315Liza.heapes@ariad.com
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Apr 2024 to May 2024
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Ariad Pharmaceuticals, Inc. (NASDAQ): 0 recent articles
More Ariad Pharmaceuticals, Inc. (MM) News Articles